Hazem Taifour

Interventional photographer📷 🫀
Chief Resident
A proud husband of @FarahHMaree ❤️
- Rochester, NY 🇺🇸
{ واذكر ربك إذا نسيت}

[Hazem Taifour @htaifourr]

Had a good time at #ACC25.

Looking forward to ACC26

[مـحـمـد الـحـمّـادي🇦🇪 @al_hammady1]

العالِم البروفيسور قتيبة حميد نائب مدير الجامعة لشؤون الكليات الطبية والعلوم الصحية في ذمة الله 💔..
ترجّل الفارس بعد مسيرة أكاديمية وعلمية حافلة ورحلة ملهمة من العطاء الأكاديمي والبحثي تاركاً خلفه إرثاً طبياً سيبقى نبراساً للأجيال..
رحم الله عزوجل البروفيسور قتيبة وغفر له وجعل ما أصابه رفعة لدرجته وتكفيراً عن سيئاته وألهمنا جميعاً الصبر والسلوان..
إنا لله وإنا إليه راجعون..

[إبراهيم الحربي Ibrahim Alharbi @Dr_ibrahimHarbi]

#TCT2025 LBCT Takeaways
Thanks to all investigators & authors for advancing our field

[JACC Journals @JACCJournals]

FFR-guided #PCI using zotarolimus DES provides significantly better long-term value than CABG for treatment of patients with multivessel CAD, with equivalent clinical outcomes at substantially lower cost. https://t.co/eXK1yE4OLF

#TCT2025 #JACC #cvCABG #cvCAD @wfearonmd

[Cardiac Trials @CardiacTrials]

Discontinuing anticoagulation after afib ablation? While standard is to continue based on CHADSVASC — this trial in contrast showed ⬇️ events with discontinuation. A practice changing trial that can improve polypharmacy and outcomes in our patients. ALONE-AF Trial, JAMA 2025 ♥️

[A.Sami Abuzaid MD,EMHL,FASE,FSCCT,FSCMR,FESC,FACC @AabuzaidDr]

Unlock the evolving landscape of cardiac amyloidosis—discover how early recognition and novel treatments can transform management for your patients.
@Amyloidosisfdn @Amyloidosis_ARC @ISA_Amyloidosis @MyASNC @amyloid_papers #ThinkAmyloid @MasriAhmadMD @estelais @roxanacampisi @gmvasilakis @Yoshito_Kadoya @Abdelcards

[Ahmed Teebi, MD MPH MSc🗝️ @Teebi_MD]

🧵Submitted your #Cardiology Fellowship application?✅

Join us for high-yield panel discussion with current fellows & faculty sharing insider tips, timelines, and strategies to help you CRUSH the #Match2025 season 💥

📅Saturday July 26
⏲️ 11:00 AM EST

@AASC_Cardiology @lamajebbawi @Deya_AlkhatibMD @Obadah1Md #MedTwitter #cardiotwitter #Epeeps

[✞ Daniel @DigitalDanielG]

Good morning from the high mountain lake

[Hazem Taifour @htaifourr]

@MarinaWahied @AnasHashem6 Thank you for your kind words Marina

[Hazem Taifour @htaifourr]

Just certified and submitted my ERAS application! Grateful for the journey so far and excited for what’s ahead. Ready for interview season! #ERAS #CardiologyFellowship

Email: [email protected]
AAMC ID: 15141477

[Hazem Taifour @htaifourr]

@rimalmorsy Thank you very much Rim!

[✞ Daniel @DigitalDanielG]

Gm

[Conrad Fischer @SeeFisch]

SGLT2 inhibitors
*Super amazing!
*Decreases progression of CKD in diabetes
*Lowers mortality in CHF with low EF
*However! Also can cause DKA with a NORMAL blood glucose. this is a VERY real adverse effect
EUGLYCEMIC DKA with SGLT2 inhibitors

[CardiovascularCorner @TrackYourHeart]

"Eyeball EF" Visual Estimation of Left Ventricular Ejection Fraction

A quick, practical method used in echo labs and at the bedside to estimate LV systolic function using real-time 2D echocardiography.

▶️ Key visual clues: Assess the degree of inward movement and thickening of the LV endocardium during end-systole relative to its size at end-diastole.

🔸 Normal EF (~55–70%):
– Good myocardial thickening
– Vigorous inward motion of walls
– Normal cavity obliteration

🔸 Mildly reduced (~35–45%):
– Wall motion reduced
– Endocardium thickens less
– Cavity smaller but not normal

🔸 Moderately reduced (~20–30%):
– Poor wall thickening
– Sluggish endocardial motion
– LV remains large in systole

🔸 Severely reduced (~10–15%):
– Barely any thickening
– Minimal cavity reduction
– Nearly akinetic walls

🔸 Hyperdynamic (>70–75%):
– Seen in volume depletion or stress states
– Cavity nearly obliterates

Tips for accurate visual estimation:
✅ Avoid LV foreshortening (elongate the chamber fully)
✅ Ensure clear visualization of endocardial borders (use tissue harmonic imaging ± contrast)
✅ Use multiple views: PLAX, A4C, PSAX-PML, A2C, ALAX

Visual EF estimation remains an essential skill for every echocardiographer. Train your eyes and correlate with Simpson’s method when possible!

📖 Ref: Based on concepts from BE Buller, MD (Echo Core Visual Guide)

#Echo #Cardiology #LVFunction #EjectionFraction #MedEd #POCUS #Ultrasound #PointOfCare

[AASC - Arab American Society of Cardiology @AASC_Cardiology]

🧵How does gender factor in prosthesis-patient mismatch (PPM) in patients undergoing TAVI? Excellent work from Dr. Karim Al-Azizi and his team at @MyJSCAI! AASC is very proud of your contributions.

https://t.co/JGK1c6iNtH

@Obadah1Md #MedTwitter

[Hazem Taifour @htaifourr]

@LaiLeoDr @HenryFordHealth @PedroMDMSc @TiberioFrisoli @jameschilee @engelpedro @HFHCardioFellow Good job! 👏🏻

[Ahmed Mohsen @drahmedmohsen85]

5 pillars for HFpEF
4 pillars for HFrEF
4 pillars for diabetic CKD
4 Pillars for AF😁

[IMCrit @IM_Crit_]

ICU Hemodynamics:

If you are managing patients with #vasoplegicshock, this is a nice review article:

[Ahmed Teebi, MD MPH MSc🗝️ @Teebi_MD]

🧵Very critical concept when discussing rhythm control/ablation strategy with patients👇

✅Symptomatic vs. asymptomatic AFib had similar risk of mortality, stroke, hospitalization, or MI.

✅Presence/absence of sx shouldn't dictate rhythm control strategy! Restoration of NSR/Ablation should still be strongly emphasized in asymptomatic AF.

👉Similar findings shown in landmark EAST-AFNET 4 trial! #Epeeps #medtwitter

[Ahmed Teebi, MD MPH MSc🗝️ @Teebi_MD]

🧵This week @YaleCardiology, we discussed Pocket Hematomas (PH) complicating PPM/ICD implants! Follow thread for take homes👇

4 Key messages:
✅PH = 5x increase in pocket infection
✅Heparin bridging = worst enemy
✅DOAC interruption is not always required
✅Triple therapy = Triple Threat (DAPT+DOAC)

#medtwitter #EPeeps

[Dr Joshua Walinjom @walinjom]

Mastering the ECG: